Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0001209191-23-022983

President and CEO sold 10,177 shares at an average $5.02 ($51,110)

  • President and CEO acquired 10,177 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Doerfler Douglas President and CEO 2023-03-31 Option exercise 10b5-1 +2,607 $0.04 $104 335,804 D: show line 1 in the form
Doerfler Douglas President and CEO 2023-03-31 Sale 10b5-1 −2,607 $5.00 $13,035 333,197 D: show line 2 in the form
Doerfler Douglas President and CEO 2023-04-03 Option exercise 10b5-1 +100 $0.04 $4 333,297 D: show line 3 in the form
Doerfler Douglas President and CEO 2023-04-03 Sale 10b5-1 −100 $5.01 $501 333,197 D: show line 4 in the form
Doerfler Douglas President and CEO 2023-04-04 Option exercise 10b5-1 +7,470 $0.04 $299 340,667 D: show line 5 in the form
Doerfler Douglas President and CEO 2023-04-04 Sale 10b5-1 −7,470 $5.03 $37,574 333,197 D: show line 6 in the form
Open-market sales · 10,177 sh · avg $5.02 · $51,110

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Doerfler Douglas President and CEO 2023-03-31 Option exercise · Employee Stock Option (right to buy) 10b5-1 −2,607 382,473 D: show line 7 in the form
Doerfler Douglas President and CEO 2023-04-03 Option exercise · Employee Stock Option (right to buy) 10b5-1 −100 382,373 D: show line 8 in the form
Doerfler Douglas President and CEO 2023-04-04 Option exercise · Employee Stock Option (right to buy) 10b5-1 −7,470 374,903 D: show line 9 in the form
Loading xslF345X04/doc4.xml…